Jacobson Pharma Announces 2018 Annual Results
- Written by Reporters
Revenue Increased 23.3% to HK$1,548.7 Million
Adjusted EBITDA Up by 20.7% to HK$397.0 Million
Profit Attributable to Shareholders Increased 12.8% to HK$202.3 Million
Recommends a Final Dividend of HK2.9 Cents per Share
HONG KONG, CHINA - Media OutReach - 25 June 2018 - Jacobson Pharma Corporation Limited("Jacobson Pharma"or the "Group"; Stock...